![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: IGLV3-21 (CAeditome ID:28796) |
Gene summary for IGLV3-21 |
![]() |
Gene information | Gene symbol | IGLV3-21 | Gene ID | 28796 |
Gene name | immunoglobulin lambda variable 3-21 | |
Synonyms | IGLV321|V2-14 | |
Cytomap | 22q11.22 | |
Type of gene | other | |
Description | Ig lambda chain V-III region LOI | |
Modification date | 20210518 | |
UniProtAcc | P80748 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
Top |
RNA A-to-I events for IGLV3-21 |
![]() |
![]() |
![]() |
![]() |
![]() |
CAediting_1464183(22712930, +), CAediting_1464184(22712967, +), CAediting_1464185(22713019, +), CAediting_1464186(22713021, +), CAediting_1464187(22713031, +), CAediting_1464188(22713154, +), CAediting_1464189(22713160, +), CAediting_1464190(22713201, +), |
Top |
RNA editing positional annotations for IGLV3-21 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
![]() |
CAeditome ID | Position | Variant type |
CAediting_1464183 | chr22_22712930_+ | exonic |
CAediting_1464184 | chr22_22712967_+ | exonic |
CAediting_1464185 | chr22_22713019_+ | exonic |
CAediting_1464186 | chr22_22713021_+ | exonic |
CAediting_1464187 | chr22_22713031_+ | exonic |
CAediting_1464188 | chr22_22713154_+ | exonic |
CAediting_1464189 | chr22_22713160_+ | exonic |
CAediting_1464190 | chr22_22713201_+ | exonic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
Top |
RNA A-to-I editing events in the alternative splicing sites for IGLV3-21 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for IGLV3-21 |
![]() * The grey color means N/A. |
![]() |
![]() |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for IGLV3-21 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for IGLV3-21 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for IGLV3-21 |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for IGLV3-21 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for IGLV3-21 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for IGLV3-21 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for IGLV3-21 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
IGLV3-21 | P80748 | DB01593 | Zinc | Immunoglobulin lambda variable 3-21 | SmallMoleculeDrug | approved|investigational |
IGLV3-21 | P80748 | DB14487 | Zinc acetate | Immunoglobulin lambda variable 3-21 | SmallMoleculeDrug | approved|investigational |
Top |
RelatedDiseases for IGLV3-21 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |